Cushing’s disease: Does low-dose pasireotide offer a comparable efficacy and safety to high-dose?
Whilst literature is expanding on pasireotide use in the management of Cushing’s disease (CD), there is still currently much unknown about long-term and low-dose pasireotide use in CD. We present a 60-year-old female with residual CD after transphenoidal surgery (TSS), being successfully managed wit...
| الحاوية / القاعدة: | Endocrinology, Diabetes & Metabolism Case Reports |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Bioscientifica
2021-03-01
|
| الوصول للمادة أونلاين: | https://edm.bioscientifica.com/view/journals/edm/2021/1/EDM20-0206.xml |